ArticleAngewandte Chemie (International ed. in English)2026
Solvent-Induced Structural Modulation in Nanoscale Covalent Organic Frameworks Enables High-Performance NO
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Covalent organic frameworks (COFs) offer exceptional structural and functional tunability, enabling performance optimization in separation, catalysis, and sensing applications. Here, we report a solvent-induced strategy for inducing structural disorder in porphyrin-based COF nanoparticles (nanoCOFs) synthesized in aqueous acetic acid, where the porphyrin units are protonated during the synthesis. Subsequent post-treatment with polar organic solvents induces deprotonation of the porphyrin units and effectively reduces the crystallinity of the nanoCOFs. The decreased crystallinity arises from solvent insertion between COF layers, which disrupts the ordered interlayer stacking and promotes structural disorder. Systematic control experiments demonstrated that the protonation-deprotonation behaviors of porphyrin units, the strength of interlayer interactions, and solvent properties (e.g., size and polarity) are key factors in regulating the framework structure and degree of structural disorder. Despite the significantly decreased surface area and reduced crystallinity, the solvent-treated nanoCOF-366, with its less compactly stacked layers, exposes more accessible porphyrin sites to guest molecules. As a result, they exhibit enhanced NO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.